Am J Physiol Cell Physiol AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (August 31, 2005). doi:10.1152/ajpcell.00206.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/C165    most recent
00206.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, L.-L.
Right arrow Articles by Johnston, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, L.-L.
Right arrow Articles by Johnston, D.
Submitted on April 29, 2005
Accepted on August 26, 2005

Acceleration of K+ channel inactivation by the MEK inhibitor U0126

Li-Lian Yuan1*, Xixi Chen1, Kumud Kunjilwar1, Paul Pfaffinger1, and Daniel Johnston1

1 Neuroscience, Baylor College of Medicine, Houston, TX, USA

* To whom correspondence should be addressed. E-mail: yuanx033{at}umn.edu.

Kv4.2-encoded A-type K+ channels play an important role in controlling neuronal excitability and are subject to modulation by various protein kinases including extracellular-signal regulated kinase (ERK). In studies of ERK modulation, the organic compound U0126 is often used to suppress the activity of MEK, which is an immediate upstream kinase of ERK. We have observed that the inactivation time constant of heterologously expressed Kv4.2 channels was accelerated by U0126 at 1-20 µM. This effect, however, was not Kv4 family specific as U0126 also converted non-inactivating K+ currents mediated by Kv1.1 subunits into transient ones. To determine whether U0126 exerted these effects through kinase inhibition, we tested U0125, a derivative of U0126 but is less potent in MEK inhibition. At the same concentrations, U0125 showed similar effects as U0126 on channel inactivation. Finally, we expressed a mutant form of Kv4.2 in which three identified ERK phosphorylation sites (T602, T607, and S616) were replaced with alanines. The inactivation of K+ currents mediated by this mutant was still accelerated by U0126. Our data favor the conclusion that the increase in the rate of channel inactivation by U0126 is likely to be independent of protein kinase inhibition and instead represents a direct action on channel gating.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Quan, H. Liu, C. Li, and L. Lou
1,4-Diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) Enhances the Cytotoxicity of Combretastatin A4 Independently of Mitogen-Activated Protein Kinase Kinase
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 326 - 333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.